Navigation Links
Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
Date:5/23/2013

ts include, but are not limited to, Omeros' expectations that it will advance OMS824 into Phase 2 clinical programs for Huntington's disease and schizophrenia this year; regarding the potential therapeutic benefits of OMS824; and that it may have capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2013. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.


'/>"/>
SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
2. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
3. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
4. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
5. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
6. Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
7. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
8. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
9. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
10. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
11. Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Research and Markets ( ... "Global Suture Industry Report 2015" report ... Industry Report 2015 is a professional and in-depth ... industry. The report provides a basic ... and industry chain structure. The suture market analysis ...
(Date:5/6/2015)... May 6, 2015 Fibich, Leebron, Copeland, Briggs ... billion settlement has been reached to resolve lawsuits involving ... medication Actos. Actos - manufactured by Takeda Pharmaceuticals - ... bladder cancer. Several of the firm,s attorneys were instrumental ... Tommy Fibich - Founding Partner of ...
(Date:5/6/2015)... and PRETORIA, South Africa , ... , cancer kills more people than HIV/AIDS, malaria and tuberculosis ... and 40 percent can be cured with the right treatment[3]. ... African nations are working to build up their radiation therapy ... of all cancer patients worldwide would benefit from radiation therapy[4] ...
Breaking Medicine Technology:Global Suture Industry Report 2015 - Forecast Trends to 2021 2Global Suture Industry Report 2015 - Forecast Trends to 2021 3Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4
(Date:5/6/2015)... OH (PRWEB) May 06, 2015 Anitha ... at Hematology Oncology Consultants, Inc. in Columbus, OH. ... and has a special focus in breast cancer, lung cancer, ... and lymphoma as well as benign hematology. , ... and internal medicine by the American Board of Internal Medicine. ...
(Date:5/6/2015)... 2015 Vancouver Chiropractic Clinic, Backs ... new blog containing the Canadian Physical Activity and ... Society for Exercise Physiology (CSEP). Since the CSEP ... and fitness research and personal training in Canada, ... highly beneficial and a rich resource for many ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 ... hand sanitizers are increasing, driven by the rising consumer ... the spread of contagious diseases. Hand washing is becoming ... of consumer apprehension over contracting infections. Periodic outbreak of ... the recent Ebola virus disease (EVD) epidemic ...
(Date:5/6/2015)... Healthcare jobs platform, JobMedic.com, ... in mid-February. The company connects hospitals, home-health, and other ... in the industry. Likewise, job seekers are able to ... Johnson, CTO, unique traffic to the site is up ... new job posting brings targeted, interested candidates to the ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 TU-Automotive has ... car and autonomous vehicles make it to the headlines ... including Ford, Nissan, GM, Volvo and Hyundai ready to ... – this is the only way for press to ... , Charlotte Wright, marketing director, TU-Automotive said “This year ...
Breaking Medicine News(10 mins):Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:Press Registration for TU-Automotive Detroit Now Open 2
... , Feb. 11 Grant Medical Center recently completed ... give hope to millions of patients facing lower limb amputations from ... the legs that affects 10 million Americans. If left untreated, it ... , The December issue of The Journal of Vascular Surgery ...
... see any blockage in arteries, study finds , THURSDAY, Feb. ... doctors whether it,s safe to discharge a patient who has ... study shows. , The coronary artery calcium scoring (CACS) test ... quickly provide doctors with a detailed image of the heart ...
... NEW YORK , Feb. 11 Oral health ... the link between poor oral health and such conditions as stroke, ... may show preliminary signs in your mouth, before other areas of ... habits can affect your oral health.  Therefore, it,s wise to pay ...
... ... in Columbia, S.C., says developments in lawsuits pending against a Pfizer anti-smoking drug don’t ... ... 2010 -- The anti-smoking patch Chantix continues to generate lawsuits from users who allege ...
... ... Products and Specially-Constructed Wood Portable Floors. "Connor Sport Court Products Well Known For ... ... (CSCI) will provide more than 65,000 square feet of Sport Court® products and a ...
... ... star John Salley is now using and officially endorsing the innovative stem cell nutrition ... ... basketball star John Salley is now using and officially endorsing the innovative stem cell ...
Cached Medicine News:Health News:New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease 2Health News:New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease 3Health News:Health 'Bites': 8 Things You Didn't Know About Your Teeth 2Health News:South Carolina Attorney Says Legal Options Still Available To Those Harmed By Chantix 2Health News:South Carolina Attorney Says Legal Options Still Available To Those Harmed By Chantix 3Health News:Connor Sport Court Lays the Ground for NBA All-Star Jam Session Presented by Adidas 2Health News:Connor Sport Court Lays the Ground for NBA All-Star Jam Session Presented by Adidas 3Health News:Health & Sports: Former NBA Star John Salley Endorses STEMTech Stem Cell Nutrition Products 2Health News:Health & Sports: Former NBA Star John Salley Endorses STEMTech Stem Cell Nutrition Products 3
... for use in 5 to 8 Fr. access ... Closer S 6F SMC System is indicated for ... common femoral artery access site of patients who ... 5 to 8F sheaths. The Closer S 6F ...
... active lifestyles of todays cardiac surgery patients ... rapid recovery and speedy return to everyday ... vessel harvesting (EVH), clinicians have been able ... a higher standard of care:, Faster ...
... Keratoconus detected early is best corrected ... acuity may still be present, GP lenses ... inevitable. GP lenses will neutralize the distortions ... visual acuity., ,Keratoconus is a fitting challenge ...
... Aumated Immunoassay Analyzer that fits in any lab ... 16 X 16 X 21 inches and weighs ... ideal for physician office laboratories, work stations for ... as well as a dedicated system for specialty ...
Medicine Products: